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| BACKGROUND
Mycobacterium leprae is the causative agent of leprosy, which shows tropism towards the cooler areas of skin, peripheral nerves, eyes, testis, etc. Of late, our group has been made tremendous efforts to understand the overt immune derangements associated with progression of the leprosy. [1] We showed that disease progression in leprosy patients results in M. leprae-infected cholesterol-depleted immature macrophages secreting high levels of TGF-β, which eventually led to induction of competitively fit CD4 + CD25 + FoxP3 + T regs [2] in MB patients. [3] We also observed an increase in CD4 + TCR γδ + cells with the disease progression. Later on, uyemura et al. [4] observed fivefold to eightfold higher frequency of γδ T cells in the peripheral blood and normal skin of granulomatous reactions in leprosy patients, whereas normal low frequency was observed in lymphoid tissues. Interestingly, only a small population (~5%) of T cells consist of TCR γ/δ chains [5] cells and reported to recognize phosphoantigens of Mycobacterium in MHC-independent manner and undergo proliferation in vitro. Also, the activation and expansion of Vγ9Vδ2 T cells are also reported in response to microbial-derived (E)-4-hydroxy-3-methyl-but-2-enylpyrophosphate (HMB-PP) and the proteins secreted from cancerous cells. Activation of Vγ9Vδ2 T cells leads to rapid production of pro-inflammatory cytokines and target cell killing. [6, 7] Therefore, in our study we have convinced that high production of HMB-PP with M. leprae proliferation in MB patients led to high proportion of these subsets, but our results doubted the high levels of IFN-γ and IL-17 in TGF-β-induced immunosuppressive environment in leprosy patients.
Herein, we studied the induction of TGF-β/SMAD3 signalling. 
| QUESTIONS ADDRESSED
The aim of this study was to identify and characterize the 
| EXPERIMENTAL DESIGN
See supplementary information (Data S1).
| RESULTS
In this study, we found 0.30±0.20%, 0.85±0.22% and 1.74±0.24% of CD4 + TCRγδ + cells in healthy controls (HC), PB and MB patients, respectively ( Figure 1A) . Surprisingly, IFN-γ & IL-17 levels in the serum showed following trend: HC>MB>PB patients, respectively (Fig. S1A) .
Further, intracellular staining of these cytokines in CD4 TGF-βRII and TGF-βRII (Fig. S2 ). 
| CONCLUSION
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. 
Data S1 Experimental design
